Enovis Corporation

NYSE:ENOV

Medical - Devices

Healthcare
$27.10 +3.50%

+$0.73 today

Market cap
$1.56B
Beta
1.49
P/E (TTM)
-1.1
EPS (TTM)
-$20.02
52W Low $20.55High $36.82

Volume 0.88M

Average 0.99M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$217.29M

FY 2025 · Annual

+91.4% YoY

Investing Cash Flow

-$179.37M

FY 2025 · Annual

Financing Cash Flow

-$52.40M

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income76.28M(11.76M)(33.26M)(824.82M)(1.18B)
Depreciation & Amortization262.92M219.71M217.1M284.8M294.38M
Deferred Income Tax(22.19M)6.32M(27.41M)(10.02M)(2.23M)
Stock-Based Compensation35.35M38.96M34.07M29.66M32.92M
Change in Working Capital(17.1M)(220.49M)(27.27M)(13.93M)15.47M
Accounts Receivables(110.99M)(45.19M)(16.32M)(57.05M)(10.75M)
Inventory(129.97M)(118.79M)(24.74M)39.07M(11.98M)
Accounts Payables178.47M(11.84M)(6.64M)13.98M(1.14M)
Other Working Capital45.38M(44.67M)20.42M(9.93M)39.34M
Other Non-Cash Items20.84M(88.59M)(28.24M)647.81M1.06B
Operating Cash Flow356.1M(55.86M)134.99M113.5M217.29M
Capital Expenditures(104.24M)(105.45M)(122.22M)(180.71M)(197.38M)
Acquisitions (Net)(223.27M)(73.68M)(152.82M)(769.91M)16.4M
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities7.03M2.75M32.57M(4.85M)1.6M
Investing Cash Flow(320.48M)(176.39M)(242.47M)(955.47M)(179.37M)
Debt Repayment(150.41M)(1.59B)217.2M859.23M(43.6M)
Common Stock Issued745.18M5.81M1.78M1.87M1.32M
Common Stock Repurchased000(4.77M)0
Dividends Paid00000
Other Financing Activities(9.87M)1.12B(91.17M)(9.51M)(10.12M)
Financing Cash Flow584.91M(465.13M)127.8M846.82M(52.4M)
Effect of Forex Changes(2.23M)2.3M219K(1.52M)2.7M
Net Change in Cash618.3M(695.08M)20.54M3.34M(11.78M)
Free Cash Flow251.86M(161.31M)12.77M(67.21M)19.92M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$1.2B
+ D&A$294.4M
+ Stock-Based Comp$32.9M
- Deferred Tax-$2.2M
+ Working Capital$15.5M
+ Other Non-Cash$1.1B
= Operating Cash Flow$217.3M
- Capex-$197.4M
= Free Cash Flow$19.9M

Analysis

FY2025 free cash flow is $19.9M. FCF conversion is -1.7% of net income. Operating cash flow was $217.3M, with capex of -$197.4M. The largest bridge item is Other Non-Cash at $1.1B.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026

Does ENOV generate free cash flow?

Enovis Corporation (ENOV) generated $19.92M of free cash flow in fiscal 2025.

How much operating cash flow does ENOV produce?

Operating cash flow was $217.29M, before capital expenditures of $197.38M.